| 货号 | 品牌 | 产品名称 | 规格 | 包装、参考价格 | |
| M832132 | MACKLIN | 美洛昔康 | 99% | 52元/5g; 181元/25g; 613元/100g; | 咨询 |
|
| M1959 | TCI | Meloxicam | >98.0%(HPLC) | 455元/5G; 1090元/25G; | 咨询 |
基本信息 | 纯度/分析方法 | >98.0%(HPLC) | | 分子式/分子量 | C14H13N3O4S2 = 351.40 | | 外观与形状(20℃) | 固体 | | 储存温度 | 0-10℃ | | 应避免的情况 | 加热 | | Reaxys-RN | 5886369 | | PubChem物质ID | 87560523 | | Merck Index (14) | 5826 | | MDL编号 | MFCD00868752 |
技术规格 | Appearance | White to Light yellow to Green powder to crystaline | | Purity(HPLC) | min. 98.0 area% | | Purity(Neutralization titration) | min. 96.0 % |
物性(参考值) 安全信息 | 图形或危害标志 |  | | 信号词 | 危险 | | 危险性说明 | H301 : 吞咽会中毒。
| | 防范说明 | P501 : 将内装物/容器送到批准的废物处理厂处理。 P270 : 使用本产品时不要进食、饮水或吸烟。 P264 : 作业后彻底清洗皮肤。 P301 + P310 + P330 : 如误吞咽:立即呼叫急救中心/医生。漱口。 P405 : 存放处须加锁。
|
相关法规 运输信息 | UN编号 | UN2811 | | 类别 | 6.1 | | 包装类别 | III | | 监管条件代码(*) | |
|
| 217197 | J&K | Meloxicam | 99%, 一种选择性COX抑制剂 | 246元/5G; 941元/25G; | 咨询 |
基本信息 | 分子式 | C14H13N3O4S2 | | 分子量 | 351.39 | | 熔点 | 255 | | MDL编码 | MFCD00868752 | | Beilstein | 5886369 | | Merck | 14,5826 | | 存储条件 | Store at 2-8℃ | 产品描述 Meloxicam 是一种选择性的COX抑制剂,用于缓解疼痛以及发烧症状。 靶点(IC50 & Targe) COX 体外研究 Meloxicam显著减少HCA-7和Moser-S集落大小。Meloxicam显著抑制HCA-7细胞集落和肿瘤生长,但是不影响COX-2阴性HCT-116细胞的生长。[1] Meloxicam抑制PGE(2)产生,增殖和侵染,尤其在表达相对较高水平COX-2的MG-63细胞中。在MG-63细胞培养中,Meloxicam引起细胞凋亡,并上调Bax mRNA和蛋白质。[2] 体内研究 在体内小鼠模型中,Meloxicam抑制LM-8肿瘤生长和肺转移。[2] 在马体内,Meloxicam注射8和24小时后,引起跛行显著减少,并有减少渗出物的倾向。在马体内,与安慰剂治疗相比,Meloxicam注射后8小时显著抑制骨液(SF)中前列腺素E2和P物质的释放,注射后24小时抑制缓激肽释放。在马体内,Meloxicam注射8小时和24小时后,减少平均MMP活性。[3] 与SS处理的马相比,Meloxicam-或flunixin-处理的马改善了术后疼痛度和临床变量。Meloxicam导致马的局部缺血损伤组织中产生大量中性粒细胞。[4] 在狗体内,Meloxicam给药在第7和21天显著抑制血液和骨液中PGE2浓度,但是不影响血液中TXB2浓度和胃黏膜中PGE2浓度。[5] 参考文献 [1] Goldman AP, et al. Carcinogenesis, 1998, 19(12), 2195-2199. [2] Naruse T, et al. Carcinogenesis, 2006, 27(3), 584-592. [3] de Grauw JC, et al. Equine Vet J, 2009, 41(7), 693-699. [4] Little D, et al. Am J Vet Res, 2007, 68(6), 614-624. [5] Jones CJ, et al. Am J Vet Res, 2002, 63(11), 1527-1531. 安全信息 | 图形或危害标志 |  | | 提示语 | Danger | | 危险说明 | H301 | | 防范说明 | P264 P270 P301+P310 P405 P501 | | UN号码 | 2811 | | 危险分类 | 6.1 | | 包装等级 | III | | RTECS | DL0702000 |
|
| R10984 | Alfa Aesar | Meloxicam Standard solution | 100ppm | 419元/1ml; | 咨询 |
|
| Y0001080 | | Meloxicam | European Pharmacopoeia (EP) Reference Standard | 1572.27元/ ; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the Issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 50 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue. 注意 Please find SDS provided by EDQM here.. 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C14H13N3O4S2 | | 分子量 | 351.40 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | EDQM | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 储存温度 | 2-8℃ | | InChI | 1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+ | | InChI key | DWMREKMVXIFPFM-ACCUITESSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 1379401 | USP | Meloxicam | United States Pharmacopeia (USP) Reference Standard | 5402.06元/400 MG; | 咨询 |
产品说明 一般描述 本产品按照发行药典的发行和规定提供。支持本产品的所有信息,包括安全数据表和任何产品信息传单,都是在发行药典的授权下开发和发布的。如需进一步信息和支持,请访问现行药典网站。 分析说明 这些产品仅供测试和化验使用。它们不适用于人类或动物,也不能用于诊断、治疗或治愈任何类型的疾病。 其他说明 USP颁布的SDS请点击此处。 可能适用相应的销售限制。 基本信息 | 经验(实验)分子式 | C14H13N3O4S2 | | 分子量 | 351.40 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | USP | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | InChI | 1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+ | | InChI key | DWMREKMVXIFPFM-ACCUITESSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| PHR1799 | Supelco | Meloxicam | Pharmaceutical Secondary Standard; Certified Reference Material | 2472.38元/500 MG; | 咨询 |
产品说明 一般描述 药物二级标准品CRM,为制药行业QC实验室及生产质量控制和研发,提供了一种方便、高性价比且符合相关法规的替代方案。 分析说明 这些二级标准品可溯源到USP、EP和BP一级标准品。 其他说明 该认证参考物质(CRM)根据ISO 17034 和 ISO/IEC 17025进行生产和认证。有关此CRM使用的所有信息均可在分析证书上找到。 附注 欲查看此物质的分析证书样本,请在下面的对话框中输入LRAB7807。这只是一个示例证书,可能与您收到的批次不符。 基本信息 | 经验(实验)分子式 | C14H13N3O4S2 | | 分子量 | 351.40 |
产品性质 | 质量水平 | 300 | | 等级 | certified reference material pharmaceutical secondary standard | | CofA | current certificate can be downloaded | | 包装 | pkg of 500 mg | | technique(s) | HPLC: suitable gas chromatography (GC): suitable | | application(s) | pharmaceutical (small molecule) | | 格式 | neat | | 药典可追溯性 | traceable to BP 629 traceable to PhEur Y0001080 traceable to USP 1379401 | | 储存温度 | 2-8℃ | | InChI | 1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+ | | InChI key | DWMREKMVXIFPFM-ACCUITESSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP629 | | Meloxicam | British Pharmacopoeia (BP) Reference Standard | 146.03元/100 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C14H13N3O4S2 | | 分子量 | 351.40 | | NACRES | NA.24 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | neat | | 储存温度 | 2-8℃ | | InChI | 1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+ | | InChI key | DWMREKMVXIFPFM-ACCUITESSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| BP630 | | Meloxicam impurity standard | British Pharmacopoeia (BP) Reference Standard | 2782.76元/100 MG; | 咨询 |
产品说明 一般描述 This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia. 包装 Unit quantity: 100 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia 其他说明 Sales restrictions may apply. 基本信息 | 经验(实验)分子式 | C14H13N3O4S2 | | 分子量 | 351.40 |
产品性质 | 等级 | pharmaceutical primary standard | | manufacturer/tradename | BP | | 格式 | mixture | | 储存温度 | 2-8℃ | | InChI | 1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+ | | InChI key | DWMREKMVXIFPFM-ACCUITESSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| 444800 | Sigma-Aldrich | Meloxicam-CAS 71125-38-7-Calbiochem | A cell-permeable, non-steroidal anti-inflammatory drug (NSAID) of the oxicam family which preferentially inhibits the inducible isoform of COX-2 (IC₅₀ = 4.7 µM) relative to COX-1 (IC& | 2566.78元/100 MG; | 咨询 |
产品说明 一般描述 A cell-permeable, non-steroidal anti-inflammatory drug (NSAID) of the oxicam family which preferentially inhibits the inducible isoform of COX-2 (IC50 = 4.7 µM) relative to COX-1 (IC50 = 36.6 µM). Also inhibits the growth of colorectal cancer cells in vitro. A cell-permeable, non-steroidal, anti-inflammatory drug (NSAID) of the oxicam family that preferentially inhibits the inducible isoform of cyclooxygenase-2 (COX-2; IC50 = 4.7 µM) relative to cyclooxygenase-1 (COX-1; IC50 = 36.6 µM). Also inhibits the growth of colorectal cancer cells in vitro. 包装 100 mg in Plastic ampoule Packaged under inert gas 生化/生理作用 Cell permeable: yes Product does not compete with ATP. Reversible: no Target IC50: 4.7 µM, 36.6 µM against the inducible isoform of COX-2 relative to COX-1, respectively Primary Target COX-2 警告 Toxicity: Standard Handling (A) 重悬 Following reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for 3 months at -20°C. 其他说明 Blanco, F.J., et al. 1999. J. Rheumatol. 26, 1366. Davies, N.M., and Skjodt, N.M. 1999. Clin. Pharmacokinet. 36, 115. Goldman, A.P., et al. 1998. Carcinogenesis 19, 2195. 法律信息 CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany 基本信息 | 经验(实验)分子式 | C14H13N3O4S2 | | 分子量 | 351.40 |
产品性质 | 质量水平 | 100 | | 测定 | ≥98% (HPLC) | | 形式 | solid | | manufacturer/tradename | Calbiochem® | | 储存条件 | OK to freeze protect from light | | 颜色 | off-white | | 溶解性 | DMSO: 10 mg/mL | | 运输 | ambient | | 储存温度 | 2-8℃ | | InChI | 1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,19H,1-2H3,(H,15,16)/b13-11+ | | InChI key | DWMREKMVXIFPFM-ACCUITESSA-N |
安全信息 | 象形图 |  | | 警示用语: | Danger | | 危险声明 | H301 | | 预防措施声明 | P264 - P270 - P301 + P310 - P405 - P501 | | 危险分类 | Acute Tox. 3 Oral | | 储存分类代码 | 6.1C - Combustible, acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects | | WGK | WGK 2 | | 闪点(F) | Not applicable | | 闪点(C) | Not applicable |
|
| M02128 | Fluorochem | Meloxicam | >99% | 220元/1g; 330元/10g; 660元/25g; | 咨询 |
基本信息 | CAS Number | 71125-38-7 | | MDL Number | MFCD00868752 |
安全信息 | 图形或危害标志 |   | | 危险性说明 | H301: Toxic if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation. H335: May cause respiratory irritation.
| | 防范说明 | P233: Keep container tightly closed. P260: Do not breathe . P261: Avoid breathing P264: Wash hands thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P271: Use only outdoors or in a well-ventilated area. P280: Wear . P301 + P310: IF SWALLOWED: Immediately call a POISON CENTER or doctor/physician. P302 + P352: IF ON SKIN: Wash with plenty of soap and water. P304: IF INHALED: . P304 + P340: IF INHALED: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P305 + P351 + P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. P312: Call a POISON CENTER or doctor/physician if you feel unwell. P321: Specific treatment (see . on this label). P330: Rinse mouth. P332 + P313: If skin irritation occurs: Get medical advice/ attention. P337 + P313: If eye irritation persists: Get medical advice/attention. P340: Remove victim to fresh air and keep at rest in a position comfortable for breathing. P362: Take off contaminated clothing and wash before reuse. P403: Store in a well-ventilated place. P403 + P233: Store in a well-ventilated place. Keep container tightly closed. P405: Store locked up. P501: Dispose of contents/container to local regulations.
|
|